SciELO - Scientific Electronic Library Online

 
vol.29 número1Inyección epidural interlaminar ecoguiada de esteroides: evaluación de rendimiento mediante el método de la suma acumulativa (CUSUM)Actualizaciones en el abordaje terapéutico en el síndrome de dolor regional complejo índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la Sociedad Española del Dolor

versão impressa ISSN 1134-8046

Resumo

LOPEZ-MOLINA, MM; LOPEZ-MOLINA, J; LOPEZ-VIDAL, J  e  GARCIA-MUNOZ, M. Use of 8 % capsaicin patches for the treatment of lumbar neuropathic pain. Rev. Soc. Esp. Dolor [online]. 2022, vol.29, n.1, pp.28-33.  Epub 05-Out-2022. ISSN 1134-8046.  https://dx.doi.org/10.20986/resed.2022.3995/2022.

Introduction:

Lumbar neuropathic pain is a common pathology in daily clinical practice, with a complex treatment, both pharmacological and interventional. These treatments can be complemented with an 8 % capsaicin transdermal patch. Capsaicin is a selective agonist of TRPV1 receptors (transient receptor vanilla 1) whose activation blocks the release of substance P, which is heavily involved in the inflammatory process.

Objectives:

To assess the usefulness of the capsaicin 8 % patch as an adjunct in patients with lumbar neuropathic pain. As a secondary objective, to assess the adverse effects of the capsaicin patch both at the time of application and after 3 months.

Patients and methods:

Retrospective, observational and descriptive study, which included 20 patients with lumbar neuropathic pain, treated with capsaicin patch 8 % (Qutenza® as an adjunct to the usual treatment of this pathology. Three tests were used to assess pain: VAS (visual analogue pain scale), DN4 and LANSS for neuropathic pain. The 3 tests were administered to the patients before the application of the patch and 3 months after the patch was applied.

Outcomes:

At baseline, 95 % of patients included in the study had very severe pain (VAS 8-9). At 3 months, 85 % of patients reported moderate pain (VAS 5-6). With respect to the DN4 test, we observed a decrease in values of slightly more than 2 points. In the LANSS test we found a decrease of more than 5 points in these 3 months. The application of the patch did not cause significant side effects.

Conclusions:

The 8 % capsaicin patch has been shown to be effective and safe as an adjunctive treatment for lumbar neuropathic pain.

Palavras-chave : Low back pain; neuropathic pain; pain management; capsaicin; transdermal patch.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )